Private Equity 8 Hours

Last updated: June 9, 2026, 11:30 AM ET

Deal Activity & Sector Shifts Dealmaking has slowed sharply this year, prompting private equity firms to look abroad while corporate buyers stay domestic, a divergence that is reshaping pipeline dynamics . Against this backdrop, Arlington announced the sale of Riverpoint Medical for $1.2bn, targeting a Q3‑2026 close and underscoring the medical‑device sector’s continued appeal to strategic buyers. Meanwhile, Inflexion‑backed Axiom GRC agreed to acquire compliance specialist MHM, expanding its footprint in SOC and ISO assurance services across North America and signaling a push into niche regulatory markets.

Mid‑Market Consolidation Mid‑size platforms are sharpening their acquisition engines. Platte River Equity completed its 100th purchase, acquiring Tallman Equipment Company, marking a milestone for the firm’s aggressive roll‑up strategy in electrical equipment. In a parallel move, Clearlake snapped up Pathway Capital, adding more than $95bn of assets under management, further consolidating private‑markets expertise and positioning the group to compete for larger infrastructure mandates. The trend extends to specialty software, where Abry Partners backed managed‑IT provider KaufmanIT to fuel cybersecurity expansion and broader platform scaling.

Infrastructure & Energy Financing The pipeline lease in Kuwait has attracted a crowded field of sovereign and private investors, with Brookfield and GIP advancing among bidders for the $7.5bn deal. The transaction, expected to raise roughly $7.5bn, reflects growing appetite for fee‑based infrastructure assets that offer stable, inflation‑linked returns amid volatile energy markets. This appetite is mirrored by Apollo and Blackstone closing a $35bn private‑credit package for Anthropic’s AI‑chip expansion, illustrating how infrastructure‑style financing is spilling over into high‑growth technology sectors.

Strategic Talent & New Verticals Private equity firms are bolstering sector expertise through targeted hires. CAZ Investments recruited Greg Grissom as executive director of sports investing, creating a dedicated mandate to source and evaluate opportunities in the rapidly commercializing sports‑media space. Similarly, Banner Capital added McKay Potter as a principal to sharpen its sourcing and execution capabilities in the Western U.S., where the firm sees heightened deal flow in its core service sectors.

Healthcare & Life‑Sciences Moves Healthcare remains a focal point for both growth and exit activity. Archimed completed the acquisition of PET‑radiopharmaceuticals developer IRAB, adding a Barcelona‑based platform that serves clinical diagnostics and trials, thereby expanding Archimed’s European life‑sciences footprint. In the U.S., TPG invested in accounting firm Smith + Howard, a move that provides the firm with capital to augment its advisory services and leverage cross‑sell opportunities across the private‑equity ecosystem.

Geographic Expansion & Leadership Changes* European firms are signaling deeper Asian ambitions. EQT appointed Gustav Segerberg as CFO, reinforcing its leadership team as it pursues larger Asian mandates, while the firm’s APAC co‑heads recently emphasized “so much more to do in Asia” in a strategic briefing . Across the Atlantic, CD&R and Platinum Equity continued to chase a 50% stake in Nestlé’s water business despite a PAI retreat, underscoring persistent interest in consumer‑essential assets even as valuation pressures mount.**

Technology‑Enabled Services & Exits The rise of AI‑enabled services is prompting both investment and exits. Thoma Bravo agreed to take validation‑software provider Kneat private for $466m, a deal that reflects strong demand for regulated‑industry automation tools. Concurrently, Permira highlighted integration and scale as critical for healthcare AI ventures, indicating that private equity is not only financing but also shaping the operational playbooks of emerging tech‑driven health companies.